Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(1R)-menthyl hexyl phosphonate group
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
(1R)-menthyl hexyl phosphonate group is a synthetic small molecule with the molecular formula C16H33O3P. It is classified as an experimental compound and has not been approved for clinical use in any country. The compound acts as a cholinesterase inhibitor, targeting cholinesterase enzymes to potentially modulate neurotransmitter breakdown. No approved indications or clinical trials have been reported for this molecule. Its structure features a menthyl moiety linked via an oxygen atom to a phosphonic acid functionalized with a hexyl chain[1][2].
- Other names
- (1R)-menthyl hexyl phosphonate grouphexyl-[(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl]oxyphosphinic acid
02
Targets
ButyrylcholinesteraseAcetylcholinesterase
Beyond the preview
Go deeper on (1R)-menthyl hexyl phosphonate group.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (1R)-menthyl hexyl phosphonate group.